blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2767298

EP2767298 - Therapeutic methods and compositions for solid delivery [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.11.2016
Database last updated on 06.07.2024
Most recent event   Tooltip18.11.2016Change or deletion - application deemed withdrawnpublished on 21.12.2016  [2016/51]
Applicant(s)For all designated states
Presage Biosciences, Inc.
530 Fairview Avenue North Suite 1000
Seattle, WA 98109 / US
[2014/34]
Inventor(s)01 / Klinghoffer, Richard
7307 56th Avenue
Seattle, WA 98115 / US
02 / Frazier, Jason
10027 62nd Avenue S
Seattle, WA 98178 / US
03 / Grenley, Marc
1610 Belmont Ave
Apt 415
Seattle, WA 98122 / US
 [2014/43]
Former [2014/36]01 / Klinghoffer, Richard
7307 56th Avenue
Seattle, WA 98115 / US
02 / Frazier, Jason
10027 62nd Avenue S
Seattle, WA 98178 / US
03 / Grenley, Marc
6044 35th Avenue Ne
Seattle, WA / US
Representative(s)Cole, William Gwyn, et al
Avidity IP
Broers Building
Hauser Forum
21 J J Thomson Avenue
Cambridge CB3 0FA / GB
[N/P]
Former [2014/34]Wilkinson, Marc George, et al
Avidity IP
Kestrel House
Falconry Court
Baker's Lane
Epping, Essex CM16 5DQ / GB
Application number, filing date14166779.023.11.2011
[2014/34]
Priority number, dateUS20100416686P23.11.2010         Original published format: US 416686 P
US20100417157P24.11.2010         Original published format: US 417157 P
US201161454115P18.03.2011         Original published format: US 201161454115 P
US201161475594P14.04.2011         Original published format: US 201161475594 P
US201161475858P15.04.2011         Original published format: US 201161475858 P
US201161483437P06.05.2011         Original published format: US 201161483437 P
[2014/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2767298
Date:20.08.2014
Language:EN
[2014/34]
Type: A3 Search report 
No.:EP2767298
Date:01.10.2014
Language:EN
[2014/40]
Search report(s)(Supplementary) European search report - dispatched on:EP01.09.2014
ClassificationIPC:A61M5/142, A61M5/32
[2014/40]
CPC:
A61M5/1408 (EP,US); A61K49/0004 (US); A61K49/0008 (US);
A61M37/00 (EP,US); A61M5/142 (US); A61M5/14212 (EP,US);
A61M5/3298 (EP,US); A61P11/00 (EP); A61P13/12 (EP);
A61P17/02 (EP); A61P19/08 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P3/10 (EP); A61P31/06 (EP); A61P31/08 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P9/00 (EP);
A61P9/04 (EP) (-)
Former IPC [2014/34]A61M5/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/34]
TitleGerman:Therapeutische Verfahren und Zusammensetzungen zur Abgabe in fester Form[2014/34]
English:Therapeutic methods and compositions for solid delivery[2014/34]
French:Procédés thérapeutiques et compositions pour administration solide[2014/34]
Examination procedure01.05.2014Examination requested  [2014/34]
07.05.2015Amendment by applicant (claims and/or description)
15.09.2015Despatch of a communication from the examining division (Time limit: M06)
26.03.2016Application deemed to be withdrawn, date of legal effect  [2016/35]
30.03.2016Application deemed to be withdrawn, date of legal effect  [2016/51]
21.04.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/51]
Parent application(s)   TooltipEP11843742.5  / EP2643045
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
07.05.2015Request for further processing filed
07.05.2015Full payment received (date of receipt of payment)
Request granted
26.05.2015Decision despatched
Fees paidRenewal fee
01.05.2014Renewal fee patent year 03
10.11.2014Renewal fee patent year 04
30.11.2015Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0774464  (COMBICHEM INC [US]) [A] 1-14 * page 15, line 56 - page 16, line 4 *;
 [A]US2003162715  (DUAN D ROXANNE [US], et al) [A] 1-14* the whole document *;
 [X]WO2009023798  (HUTCHINSON FRED CANCER RES [US], et al) [X] 1-14 * figure 7; claim 74 * * page 14, line 14 - page 15, line 25 *
by applicantUS4014335
 US4164559
 US4897268
 US4988617
 US5030002
 US5041538
 US5075109
 US5137809
 US5139941
 US5173414
 US5242794
 WO9513365
 WO9513392
 US5494810
 WO9617947
 US5599672
 WO9706243
 WO9708298
 WO9709441
 US5627037
 EP0774464
 WO9721825
 US5658776
 WO9809657
 US5751629
 US5786211
 US5789172
 US5798035
 US5858351
 US5871982
 WO9911764
 US5935788
 US5942420
 US6258595
 US6410232
 US2003022207
 US2003044781
 US6537966
 US6566118
 US6582938
 US2005100932
 US6953662
 US2006024711
 US2006024678
 US2007254041
    - TUNGGAL ET AL., CLIN. CANC. RES, (1999), vol. 5, page 1583
    - IGNATIADIS ET AL., PATHOBIOL, (2008), vol. 75, page 104
    - CURR. DRUG DISCOV. TECHNOL., vol. 5, page 9
    - AUMAN ET AL., DRUG METAB. REV., (2008), vol. 40, page 303
    - TALMADGE ET AL., AM. J. PATHOL., (2007), vol. 170, page 793
    - KERBEL, CANC. BIOL. THERAP., (2003), vol. 2, no. 4, page 134
    - MAN ET AL., CANC. MET. REV., (2007), vol. 26, page 737
    - CESPEDES ET AL., CLIN. TRANSL ONCOL., (2006), vol. 8, page 318
    - VEISEH ET AL., CANC. RES., (2007), vol. 67, page 6882
    - ANNUAL REVIEW OF BIOPHYSICS AND BIOENGINEERING, (1974), vol. 3, pages 231 - 253
    - M.A. HAYAT, Cancer Iniaging, ACADEMIC PRESS, (2007), vol. 1, 2
    - CHAN ET AL., "DNA Mapping Using Micr ofluidic Stretching and Single-Molecule Detection of Fluorescent Site-Specific Tags", GENOME RESEARCH, (2004), vol. 14, pages 1137 - 1146
    - MARGUILES ET AL., NATURE, (2005), vol. 437, no. 7057, pages 376 - 80
    - HONG, S ET AL., NAT. BIOTECHNOL., (2004), vol. 22, no. 4, pages 435 - 9
    - BENNETT, B. ET AL., PHARMACOGENOMICS, (2005), vol. 6, no. 4, pages 373 - 82
    - SHENDURE, P. ET AL., SCIENCE, (2005), vol. 309, no. 5741, pages 1728 - 32
    - LEBKOWSKI ET AL., MOL CELL BIOL, (1988), vol. 8, pages 3988 - 3996
    - CARTER B J, CURRENT OPINION IN BIOTECHNOLOGY, (1992), vol. 3, pages 533 - 539
    - ZHOU ET AL., J. EXP. MED., (1994), vol. 179, pages 1867 - 1875
    - XIAO ET AL., J. VIROL., (1998), vol. 72, pages 2224 - 32
    - LI ET AL., NAT BIOTECHNOL, (1999), vol. 17, pages 241 - 245
    - SAMULSKI ET AL., PROC. NATL. ACAD. S6. USA, (1982), vol. 79, pages 2077 - 2081
    - LAUGHLIN ET AL., GENE, (1983), vol. 23, pages 65 - 73
    - SENAPATHY; CARTER, J. BIOI. CHERN, (1984), vol. 259, pages 4661 - 4666
    - CARTER, CURRENT OPINIONS IN BIOTECHNOLOGY, (1992), pages 1533 - 539
    - MUZYCZKA, CURR. TOPICS IN MICROBIAL. AND IMMUNOL., (1992), vol. 158, pages 97 - 129
    - RATSCHIN ET AL., MOL. CELL. BIOL., (1984), vol. 4, page 2072
    - HERMONAT ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, page 6466
    - TRATSCHIN ET AL., MOL. CELL. BIOL., (1985), vol. 5, page 3251 1
    - MCLAUGHLIN, J. VIROL., (1988), vol. 62, page 1963
    - LEBKOWSKI ET AL., MOL. CELL. BIOL., (1988), vol. 7, page 349
    - SAMULSKI ET AL., J. VIROL., (1989), vol. 63, pages 3822 - 3828
    - PERRIN ET AL., GENE THERAPY, vol. 4, pages 609 - 615
    - CLARK ET AL., GENE THERAPY, (1996), vol. 3, pages 1124 - 1132
    - GRAHAM ET AL., J. GEN. VIROL., (1977), vol. 36, page 59
    - AIELLO ET AL., VIROLOGY, (1979), vol. 94, page 460
    - MUZYCZKA, N., CURRENT TOPICS IN MICROBIOL. AND IMMUNOL., (1992), vol. 158, pages 97 - 129
    - KOTIN, R. M, HUMAN GENE THERAPY, (1994), vol. 5, pages 793 - 801
    - THOMSON ET AL., VIROLOGY, (1994), vol. 204, pages 304 - 311
    - SAMULSKI ET AL., J. VIOL., (1989), vol. 63, pages 3822 - 3828
    - MCCARTY ET AL., J. VIROL., (1991), vol. 65, pages 2936 - 2945
    - CLARK ET AL., HUM. GENE THER., (1999), vol. 10, no. 6, pages 1031 - 1039
    - SCHENPP; CLARK, METHODS MOL. MED., (2002), pages 69427 - 443
    - PITTENGER ET AL., SCIENCE, (1999), vol. 284, no. 2, pages 143 - 147
    - HUARD ET AL., CURR. OPIN. BIOTECHNOL., (2004), vol. 15, no. 5, pages 419 - 23
    - TINSLEY ET AL., NATURE, (1992), vol. 360, pages 591 - 593
    - KOENIG ET AL., CELL, (1988), vol. 53, pages 219 - 216
    - TINSLEY ET AL., NATURE, (1996), vol. 384, pages 349 - 353
    - DECONINCK ET AL., NAT MED., (1997), vol. 3, pages 1216 - 21
    - RAFAEL ET AL., NAT GENET., (1998), vol. 19, pages 79 - 82
    - MCPHERRON ET AL., NATURE, (1997), vol. 387, no. 6628, pages 83 - 90
    - MCPHERRON ET AL., NAT. GENET., (1999), vol. 22, no. 3, pages 260 - 264
    - HILL ET AL., J. BIOL. CHEM., (2002), vol. 277, no. 43, pages 40735 - 40741
    - HILL ET AL., MOL ENDOCRINOL, (2003), vol. 17, pages 1144 - 1154
    - WEINTRAUB ET AL., SCIENCE, (1991), vol. 251, pages 761 - 766
    - CSERJESI; OLSON, MOL. CELL BIOL., (1991), vol. 11, pages 4854 - 4862
    - MUSCAT ET AL., MOL. CELL BIOL, (1987), vol. 7, pages 4089 - 4099
    - JOHNSON ET AL., MOL. CELL BIOL., (1989), vol. 9, pages 3393 - 3399
    - SEMENZA ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 5680 - 5684
    - SEMENZA ET AL., J. BIOL. CHEM., vol. 269, pages 23757 - 23763
    - MADER; WHITE, PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5603 - 5607
    - DHAWAN ET AL., SOMAT. CELL. MOL. GENET., (1995), vol. 21, pages 233 - 240
    - SHOCKETT ET AL., PROC. NATL. ACAD. SCI. USA, (1995), vol. 92, pages 6522 - 6526
    - MAN ET AL., CANC. MET. REV, (2007), vol. 26, page 737
    - CESPEDES ET AL., CLIN. TRANSL ONCOL, (2006), vol. 8, page 318
    - KERR ET AL., CANC. CHEMOTHER. PHANNACOL., (1987), vol. 19, page 1
    - NEDERMAN ET AL., IN VITRO, (1981), vol. 17, page 290
    - DURAND, CANC. RES., (1981), vol. 41, page 3495
    - DURAND, JNCI, (1989), vol. 81, page 146
    - TUNGGAL ET AL., CLIN. CANC. RES., (1999), vol. 5, page 1583
 US20100189794
 WO1991US04666
 WO1991US08694
 WO1994US08542
 US20000572530
 WO2008US73212
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.